Related references
Note: Only part of the references are listed.Efficacy of sentinel lymph node mapping in endometrial cancer with low- or high-intermediate risk
Yu Xue et al.
JOURNAL OF SURGICAL ONCOLOGY (2022)
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Lymphedema and Post-Operative Complications after Sentinel Lymph Node Biopsy versus Lymphadenectomy in Endometrial Carcinomas-A Systematic Review and Meta-Analysis
Rianne J. A. Helgers et al.
JOURNAL OF CLINICAL MEDICINE (2021)
A cost-effectiveness analysis of three approaches for lymph node assessment in patients with low- and intermediate-risk endometrial cancer
Lara C. Burg et al.
GYNECOLOGIC ONCOLOGY (2021)
Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
Maria C. Cusimano et al.
JAMA SURGERY (2021)
Impact of Sentinel Node Mapping in Decreasing the Risk of Lymphocele in Endometrial Cancer
Thiago Pereira Diniz et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure
Amanda J. Stephens et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001)
Salih Taskin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: Long-term results of a propensity-matched analysis
Giorgio Bogani et al.
GYNECOLOGIC ONCOLOGY (2020)
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers
Nadeem R. Abu-Rustum et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Patients' and gynecologists' views on sentinel lymph node mapping in low- and intermediate-risk endometrial cancer: a Dutch vignette study
Johanna W. M. Aarts et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Prognostic significance of hormone receptor (ER/PR) status in endometrial carcinoma in black women: Implications with lymph node metastasis.
Manan Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group
Antonino Ditto et al.
EUROPEAN JOURNAL OF CANCER (2020)
Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739)
Floor J. Backes et al.
GYNECOLOGIC ONCOLOGY (2019)
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2019)
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
Daniela Matei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
Lei Ye et al.
ONCOLOGIST (2019)
Low-Volume Lymph Node Metastases in Endometrial Carcinoma
Lani K. Clinton et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
Emma C. Rossi et al.
LANCET ONCOLOGY (2017)
Accuracy of Endometrial Sampling in Endometrial Carcinoma A Systematic Review and Meta-analysis
Nicole C. M. Visser et al.
OBSTETRICS AND GYNECOLOGY (2017)
Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis
Anna Jo Bodurtha Smith et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye
Alessandro Buda et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis
Ilary Ruscito et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer
Andrea Papadia et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models
Bingyi Yang et al.
PLOS ONE (2016)
Staging for endometrial cancer: The controversy around lymphadenectomy - Can this be resolved?
Martin Koskas et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2015)
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
Joanna IntHout et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Lymphedema After Surgery for Endometrial Cancer Prevalence, Risk Factors, and Quality of Life
Kathleen J. Yost et al.
OBSTETRICS AND GYNECOLOGY (2014)
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
Jone Trovik et al.
EUROPEAN JOURNAL OF CANCER (2013)
Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer
M. M. Leitao et al.
GYNECOLOGIC ONCOLOGY (2013)
Sentinel lymph node in endometrial cancer: A systematic review on laparoscopic detection
Nor Anita Abdullah et al.
GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT (2013)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells
Gerta Ruecker et al.
STATISTICS IN MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Share Paper
